Liu and colleagues found that EP ameliorates monocrotaline-induced pulmonary arterial hypertension and reverses pulmonary vascular remolding in rats by inhibiting the release of TNF-α and IL-6 and by reducing the expression of endothelin-1 [38]. The gene discussed is EDN1; the disease is pulmonary arterial hypertension.